世界の卵巣がん分子診断市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Ovarian Cancer Molecular Diagnostics Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4637 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、卵巣がん分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・卵巣がん分子診断の市場動向 ・企業の競争状況、市場シェア ・卵巣がん分子診断の種類別市場規模と予測2016-2027（PCR、FISH、DNAシーケンシング、ジーンチップ） ・卵巣がん分子診断の用途別市場規模と予測2016-2027（臨床診断、薬物スクリーニング、研究） ・卵巣がん分子診断の北米市場規模2016-2027（アメリカ、カナダ） ・卵巣がん分子診断の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・卵巣がん分子診断のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・卵巣がん分子診断の中南米市場規模2016-2027（メキシコ、ブラジル） ・卵巣がん分子診断の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Roche、Foundationmedicine、Tellgen、Sansure、Premed、Berryoncology、Helixgen、Annoroad、Topgen、Geneis） ・結論

A molecular approach for diagnosing ovarian cancer

Market Analysis and Insights: Global Ovarian Cancer Molecular Diagnostics Market
The global Ovarian Cancer Molecular Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Ovarian Cancer Molecular Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Ovarian Cancer Molecular Diagnostics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Ovarian Cancer Molecular Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Ovarian Cancer Molecular Diagnostics market.

Global Ovarian Cancer Molecular Diagnostics Scope and Market Size
Ovarian Cancer Molecular Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Ovarian Cancer Molecular Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
PCR
FISH
DNA Sequencing
Gene Chip

Segment by Application
Clinical Diagnosis
Drug Screening
Research

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Roche
Foundationmedicine
Tellgen
Sansure
Premed
Berryoncology
Helixgen
Annoroad
Topgen
Geneis

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Ovarian Cancer Molecular Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 PCR
1.2.3 FISH
1.2.4 DNA Sequencing
1.2.5 Gene Chip
1.3 Market by Application
1.3.1 Global Ovarian Cancer Molecular Diagnostics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Clinical Diagnosis
1.3.3 Drug Screening
1.3.4 Research
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Ovarian Cancer Molecular Diagnostics Market Perspective (2016-2027)
2.2 Ovarian Cancer Molecular Diagnostics Growth Trends by Regions
2.2.1 Ovarian Cancer Molecular Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Ovarian Cancer Molecular Diagnostics Historic Market Share by Regions (2016-2021)
2.2.3 Ovarian Cancer Molecular Diagnostics Forecasted Market Size by Regions (2022-2027)
2.3 Ovarian Cancer Molecular Diagnostics Industry Dynamic
2.3.1 Ovarian Cancer Molecular Diagnostics Market Trends
2.3.2 Ovarian Cancer Molecular Diagnostics Market Drivers
2.3.3 Ovarian Cancer Molecular Diagnostics Market Challenges
2.3.4 Ovarian Cancer Molecular Diagnostics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Ovarian Cancer Molecular Diagnostics Players by Revenue
3.1.1 Global Top Ovarian Cancer Molecular Diagnostics Players by Revenue (2016-2021)
3.1.2 Global Ovarian Cancer Molecular Diagnostics Revenue Market Share by Players (2016-2021)
3.2 Global Ovarian Cancer Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Ovarian Cancer Molecular Diagnostics Revenue
3.4 Global Ovarian Cancer Molecular Diagnostics Market Concentration Ratio
3.4.1 Global Ovarian Cancer Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Ovarian Cancer Molecular Diagnostics Revenue in 2020
3.5 Ovarian Cancer Molecular Diagnostics Key Players Head office and Area Served
3.6 Key Players Ovarian Cancer Molecular Diagnostics Product Solution and Service
3.7 Date of Enter into Ovarian Cancer Molecular Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Ovarian Cancer Molecular Diagnostics Breakdown Data by Type
4.1 Global Ovarian Cancer Molecular Diagnostics Historic Market Size by Type (2016-2021)
4.2 Global Ovarian Cancer Molecular Diagnostics Forecasted Market Size by Type (2022-2027)

5 Ovarian Cancer Molecular Diagnostics Breakdown Data by Application
5.1 Global Ovarian Cancer Molecular Diagnostics Historic Market Size by Application (2016-2021)
5.2 Global Ovarian Cancer Molecular Diagnostics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Ovarian Cancer Molecular Diagnostics Market Size (2016-2027)
6.2 North America Ovarian Cancer Molecular Diagnostics Market Size by Type
6.2.1 North America Ovarian Cancer Molecular Diagnostics Market Size by Type (2016-2021)
6.2.2 North America Ovarian Cancer Molecular Diagnostics Market Size by Type (2022-2027)
6.2.3 North America Ovarian Cancer Molecular Diagnostics Market Size by Type (2016-2027)
6.3 North America Ovarian Cancer Molecular Diagnostics Market Size by Application
6.3.1 North America Ovarian Cancer Molecular Diagnostics Market Size by Application (2016-2021)
6.3.2 North America Ovarian Cancer Molecular Diagnostics Market Size by Application (2022-2027)
6.3.3 North America Ovarian Cancer Molecular Diagnostics Market Size by Application (2016-2027)
6.4 North America Ovarian Cancer Molecular Diagnostics Market Size by Country
6.4.1 North America Ovarian Cancer Molecular Diagnostics Market Size by Country (2016-2021)
6.4.2 North America Ovarian Cancer Molecular Diagnostics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Ovarian Cancer Molecular Diagnostics Market Size (2016-2027)
7.2 Europe Ovarian Cancer Molecular Diagnostics Market Size by Type
7.2.1 Europe Ovarian Cancer Molecular Diagnostics Market Size by Type (2016-2021)
7.2.2 Europe Ovarian Cancer Molecular Diagnostics Market Size by Type (2022-2027)
7.2.3 Europe Ovarian Cancer Molecular Diagnostics Market Size by Type (2016-2027)
7.3 Europe Ovarian Cancer Molecular Diagnostics Market Size by Application
7.3.1 Europe Ovarian Cancer Molecular Diagnostics Market Size by Application (2016-2021)
7.3.2 Europe Ovarian Cancer Molecular Diagnostics Market Size by Application (2022-2027)
7.3.3 Europe Ovarian Cancer Molecular Diagnostics Market Size by Application (2016-2027)
7.4 Europe Ovarian Cancer Molecular Diagnostics Market Size by Country
7.4.1 Europe Ovarian Cancer Molecular Diagnostics Market Size by Country (2016-2021)
7.4.2 Europe Ovarian Cancer Molecular Diagnostics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Ovarian Cancer Molecular Diagnostics Market Size (2016-2027)
8.2 Asia-Pacific Ovarian Cancer Molecular Diagnostics Market Size by Type
8.2.1 Asia-Pacific Ovarian Cancer Molecular Diagnostics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Ovarian Cancer Molecular Diagnostics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Ovarian Cancer Molecular Diagnostics Market Size by Type (2016-2027)
8.3 Asia-Pacific Ovarian Cancer Molecular Diagnostics Market Size by Application
8.3.1 Asia-Pacific Ovarian Cancer Molecular Diagnostics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Ovarian Cancer Molecular Diagnostics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Ovarian Cancer Molecular Diagnostics Market Size by Application (2016-2027)
8.4 Asia-Pacific Ovarian Cancer Molecular Diagnostics Market Size by Region
8.4.1 Asia-Pacific Ovarian Cancer Molecular Diagnostics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Ovarian Cancer Molecular Diagnostics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Ovarian Cancer Molecular Diagnostics Market Size (2016-2027)
9.2 Latin America Ovarian Cancer Molecular Diagnostics Market Size by Type
9.2.1 Latin America Ovarian Cancer Molecular Diagnostics Market Size by Type (2016-2021)
9.2.2 Latin America Ovarian Cancer Molecular Diagnostics Market Size by Type (2022-2027)
9.2.3 Latin America Ovarian Cancer Molecular Diagnostics Market Size by Type (2016-2027)
9.3 Latin America Ovarian Cancer Molecular Diagnostics Market Size by Application
9.3.1 Latin America Ovarian Cancer Molecular Diagnostics Market Size by Application (2016-2021)
9.3.2 Latin America Ovarian Cancer Molecular Diagnostics Market Size by Application (2022-2027)
9.3.3 Latin America Ovarian Cancer Molecular Diagnostics Market Size by Application (2016-2027)
9.4 Latin America Ovarian Cancer Molecular Diagnostics Market Size by Country
9.4.1 Latin America Ovarian Cancer Molecular Diagnostics Market Size by Country (2016-2021)
9.4.2 Latin America Ovarian Cancer Molecular Diagnostics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Ovarian Cancer Molecular Diagnostics Market Size (2016-2027)
10.2 Middle East & Africa Ovarian Cancer Molecular Diagnostics Market Size by Type
10.2.1 Middle East & Africa Ovarian Cancer Molecular Diagnostics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Ovarian Cancer Molecular Diagnostics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Ovarian Cancer Molecular Diagnostics Market Size by Type (2016-2027)
10.3 Middle East & Africa Ovarian Cancer Molecular Diagnostics Market Size by Application
10.3.1 Middle East & Africa Ovarian Cancer Molecular Diagnostics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Ovarian Cancer Molecular Diagnostics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Ovarian Cancer Molecular Diagnostics Market Size by Application (2016-2027)
10.4 Middle East & Africa Ovarian Cancer Molecular Diagnostics Market Size by Country
10.4.1 Middle East & Africa Ovarian Cancer Molecular Diagnostics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Ovarian Cancer Molecular Diagnostics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Ovarian Cancer Molecular Diagnostics Introduction
11.1.4 Roche Revenue in Ovarian Cancer Molecular Diagnostics Business (2016-2021)
11.1.5 Roche Recent Development
11.2 Foundationmedicine
11.2.1 Foundationmedicine Company Details
11.2.2 Foundationmedicine Business Overview
11.2.3 Foundationmedicine Ovarian Cancer Molecular Diagnostics Introduction
11.2.4 Foundationmedicine Revenue in Ovarian Cancer Molecular Diagnostics Business (2016-2021)
11.2.5 Foundationmedicine Recent Development
11.3 Tellgen
11.3.1 Tellgen Company Details
11.3.2 Tellgen Business Overview
11.3.3 Tellgen Ovarian Cancer Molecular Diagnostics Introduction
11.3.4 Tellgen Revenue in Ovarian Cancer Molecular Diagnostics Business (2016-2021)
11.3.5 Tellgen Recent Development
11.4 Sansure
11.4.1 Sansure Company Details
11.4.2 Sansure Business Overview
11.4.3 Sansure Ovarian Cancer Molecular Diagnostics Introduction
11.4.4 Sansure Revenue in Ovarian Cancer Molecular Diagnostics Business (2016-2021)
11.4.5 Sansure Recent Development
11.5 Premed
11.5.1 Premed Company Details
11.5.2 Premed Business Overview
11.5.3 Premed Ovarian Cancer Molecular Diagnostics Introduction
11.5.4 Premed Revenue in Ovarian Cancer Molecular Diagnostics Business (2016-2021)
11.5.5 Premed Recent Development
11.6 Berryoncology
11.6.1 Berryoncology Company Details
11.6.2 Berryoncology Business Overview
11.6.3 Berryoncology Ovarian Cancer Molecular Diagnostics Introduction
11.6.4 Berryoncology Revenue in Ovarian Cancer Molecular Diagnostics Business (2016-2021)
11.6.5 Berryoncology Recent Development
11.7 Helixgen
11.7.1 Helixgen Company Details
11.7.2 Helixgen Business Overview
11.7.3 Helixgen Ovarian Cancer Molecular Diagnostics Introduction
11.7.4 Helixgen Revenue in Ovarian Cancer Molecular Diagnostics Business (2016-2021)
11.7.5 Helixgen Recent Development
11.8 Annoroad
11.8.1 Annoroad Company Details
11.8.2 Annoroad Business Overview
11.8.3 Annoroad Ovarian Cancer Molecular Diagnostics Introduction
11.8.4 Annoroad Revenue in Ovarian Cancer Molecular Diagnostics Business (2016-2021)
11.8.5 Annoroad Recent Development
11.9 Topgen
11.9.1 Topgen Company Details
11.9.2 Topgen Business Overview
11.9.3 Topgen Ovarian Cancer Molecular Diagnostics Introduction
11.9.4 Topgen Revenue in Ovarian Cancer Molecular Diagnostics Business (2016-2021)
11.9.5 Topgen Recent Development
11.10 Geneis
11.10.1 Geneis Company Details
11.10.2 Geneis Business Overview
11.10.3 Geneis Ovarian Cancer Molecular Diagnostics Introduction
11.10.4 Geneis Revenue in Ovarian Cancer Molecular Diagnostics Business (2016-2021)
11.10.5 Geneis Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Ovarian Cancer Molecular Diagnostics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of PCR
Table 3. Key Players of FISH
Table 4. Key Players of DNA Sequencing
Table 5. Key Players of Gene Chip
Table 6. Global Ovarian Cancer Molecular Diagnostics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Ovarian Cancer Molecular Diagnostics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Ovarian Cancer Molecular Diagnostics Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Ovarian Cancer Molecular Diagnostics Market Share by Regions (2016-2021)
Table 10. Global Ovarian Cancer Molecular Diagnostics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Ovarian Cancer Molecular Diagnostics Market Share by Regions (2022-2027)
Table 12. Ovarian Cancer Molecular Diagnostics Market Trends
Table 13. Ovarian Cancer Molecular Diagnostics Market Drivers
Table 14. Ovarian Cancer Molecular Diagnostics Market Challenges
Table 15. Ovarian Cancer Molecular Diagnostics Market Restraints
Table 16. Global Ovarian Cancer Molecular Diagnostics Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Ovarian Cancer Molecular Diagnostics Market Share by Players (2016-2021)
Table 18. Global Top Ovarian Cancer Molecular Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ovarian Cancer Molecular Diagnostics as of 2020)
Table 19. Ranking of Global Top Ovarian Cancer Molecular Diagnostics Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Ovarian Cancer Molecular Diagnostics Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Ovarian Cancer Molecular Diagnostics Product Solution and Service
Table 23. Date of Enter into Ovarian Cancer Molecular Diagnostics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Ovarian Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Ovarian Cancer Molecular Diagnostics Revenue Market Share by Type (2016-2021)
Table 27. Global Ovarian Cancer Molecular Diagnostics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Ovarian Cancer Molecular Diagnostics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Ovarian Cancer Molecular Diagnostics Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Ovarian Cancer Molecular Diagnostics Revenue Market Share by Application (2016-2021)
Table 31. Global Ovarian Cancer Molecular Diagnostics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Ovarian Cancer Molecular Diagnostics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Ovarian Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Ovarian Cancer Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Ovarian Cancer Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Ovarian Cancer Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Ovarian Cancer Molecular Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Ovarian Cancer Molecular Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Ovarian Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Ovarian Cancer Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Ovarian Cancer Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Ovarian Cancer Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Ovarian Cancer Molecular Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Ovarian Cancer Molecular Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Ovarian Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Ovarian Cancer Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Ovarian Cancer Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Ovarian Cancer Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Ovarian Cancer Molecular Diagnostics Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Ovarian Cancer Molecular Diagnostics Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Ovarian Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Ovarian Cancer Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Ovarian Cancer Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Ovarian Cancer Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Ovarian Cancer Molecular Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Ovarian Cancer Molecular Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Ovarian Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Ovarian Cancer Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Ovarian Cancer Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Ovarian Cancer Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Ovarian Cancer Molecular Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Ovarian Cancer Molecular Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 63. Roche Company Details
Table 64. Roche Business Overview
Table 65. Roche Ovarian Cancer Molecular Diagnostics Product
Table 66. Roche Revenue in Ovarian Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 67. Roche Recent Development
Table 68. Foundationmedicine Company Details
Table 69. Foundationmedicine Business Overview
Table 70. Foundationmedicine Ovarian Cancer Molecular Diagnostics Product
Table 71. Foundationmedicine Revenue in Ovarian Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 72. Foundationmedicine Recent Development
Table 73. Tellgen Company Details
Table 74. Tellgen Business Overview
Table 75. Tellgen Ovarian Cancer Molecular Diagnostics Product
Table 76. Tellgen Revenue in Ovarian Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 77. Tellgen Recent Development
Table 78. Sansure Company Details
Table 79. Sansure Business Overview
Table 80. Sansure Ovarian Cancer Molecular Diagnostics Product
Table 81. Sansure Revenue in Ovarian Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 82. Sansure Recent Development
Table 83. Premed Company Details
Table 84. Premed Business Overview
Table 85. Premed Ovarian Cancer Molecular Diagnostics Product
Table 86. Premed Revenue in Ovarian Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 87. Premed Recent Development
Table 88. Berryoncology Company Details
Table 89. Berryoncology Business Overview
Table 90. Berryoncology Ovarian Cancer Molecular Diagnostics Product
Table 91. Berryoncology Revenue in Ovarian Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 92. Berryoncology Recent Development
Table 93. Helixgen Company Details
Table 94. Helixgen Business Overview
Table 95. Helixgen Ovarian Cancer Molecular Diagnostics Product
Table 96. Helixgen Revenue in Ovarian Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 97. Helixgen Recent Development
Table 98. Annoroad Company Details
Table 99. Annoroad Business Overview
Table 100. Annoroad Revenue in Ovarian Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 101. Annoroad Recent Development
Table 102. Topgen Company Details
Table 103. Topgen Business Overview
Table 104. Topgen Ovarian Cancer Molecular Diagnostics Product
Table 105. Topgen Revenue in Ovarian Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 106. Topgen Recent Development
Table 107. Geneis Company Details
Table 108. Geneis Business Overview
Table 109. Geneis Ovarian Cancer Molecular Diagnostics Product
Table 110. Geneis Revenue in Ovarian Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 111. Geneis Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Ovarian Cancer Molecular Diagnostics Market Share by Type: 2020 VS 2027
Figure 2. PCR Features
Figure 3. FISH Features
Figure 4. DNA Sequencing Features
Figure 5. Gene Chip Features
Figure 6. Global Ovarian Cancer Molecular Diagnostics Market Share by Application: 2020 VS 2027
Figure 7. Clinical Diagnosis Case Studies
Figure 8. Drug Screening Case Studies
Figure 9. Research Case Studies
Figure 10. Ovarian Cancer Molecular Diagnostics Report Years Considered
Figure 11. Global Ovarian Cancer Molecular Diagnostics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Ovarian Cancer Molecular Diagnostics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Ovarian Cancer Molecular Diagnostics Market Share by Regions: 2020 VS 2027
Figure 14. Global Ovarian Cancer Molecular Diagnostics Market Share by Regions (2022-2027)
Figure 15. Global Ovarian Cancer Molecular Diagnostics Market Share by Players in 2020
Figure 16. Global Top Ovarian Cancer Molecular Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ovarian Cancer Molecular Diagnostics as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Ovarian Cancer Molecular Diagnostics Revenue in 2020
Figure 18. Global Ovarian Cancer Molecular Diagnostics Revenue Market Share by Type (2016-2021)
Figure 19. Global Ovarian Cancer Molecular Diagnostics Revenue Market Share by Type (2022-2027)
Figure 20. North America Ovarian Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Ovarian Cancer Molecular Diagnostics Market Share by Type (2016-2027)
Figure 22. North America Ovarian Cancer Molecular Diagnostics Market Share by Application (2016-2027)
Figure 23. North America Ovarian Cancer Molecular Diagnostics Market Share by Country (2016-2027)
Figure 24. United States Ovarian Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Ovarian Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Ovarian Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Ovarian Cancer Molecular Diagnostics Market Share by Type (2016-2027)
Figure 28. Europe Ovarian Cancer Molecular Diagnostics Market Share by Application (2016-2027)
Figure 29. Europe Ovarian Cancer Molecular Diagnostics Market Share by Country (2016-2027)
Figure 30. Germany Ovarian Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Ovarian Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Ovarian Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Ovarian Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Ovarian Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Ovarian Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Ovarian Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Ovarian Cancer Molecular Diagnostics Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Ovarian Cancer Molecular Diagnostics Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Ovarian Cancer Molecular Diagnostics Market Share by Region (2016-2027)
Figure 40. China Ovarian Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Ovarian Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Ovarian Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Ovarian Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Ovarian Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Ovarian Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Ovarian Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Ovarian Cancer Molecular Diagnostics Market Share by Type (2016-2027)
Figure 48. Latin America Ovarian Cancer Molecular Diagnostics Market Share by Application (2016-2027)
Figure 49. Latin America Ovarian Cancer Molecular Diagnostics Market Share by Country (2016-2027)
Figure 50. Mexico Ovarian Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Ovarian Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Ovarian Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Ovarian Cancer Molecular Diagnostics Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Ovarian Cancer Molecular Diagnostics Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Ovarian Cancer Molecular Diagnostics Market Share by Country (2016-2027)
Figure 56. Turkey Ovarian Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Ovarian Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Ovarian Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Roche Revenue Growth Rate in Ovarian Cancer Molecular Diagnostics Business (2016-2021)
Figure 60. Foundationmedicine Revenue Growth Rate in Ovarian Cancer Molecular Diagnostics Business (2016-2021)
Figure 61. Tellgen Revenue Growth Rate in Ovarian Cancer Molecular Diagnostics Business (2016-2021)
Figure 62. Sansure Revenue Growth Rate in Ovarian Cancer Molecular Diagnostics Business (2016-2021)
Figure 63. Premed Revenue Growth Rate in Ovarian Cancer Molecular Diagnostics Business (2016-2021)
Figure 64. Berryoncology Revenue Growth Rate in Ovarian Cancer Molecular Diagnostics Business (2016-2021)
Figure 65. Helixgen Revenue Growth Rate in Ovarian Cancer Molecular Diagnostics Business (2016-2021)
Figure 66. Annoroad Revenue Growth Rate in Ovarian Cancer Molecular Diagnostics Business (2016-2021)
Figure 67. Topgen Revenue Growth Rate in Ovarian Cancer Molecular Diagnostics Business (2016-2021)
Figure 68. Geneis Revenue Growth Rate in Ovarian Cancer Molecular Diagnostics Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

---